Client: VISKA.BIO
Agency: Digizyme, Inc.
Contribution: Worked with team members and led storyboarding and animation
Year: 2024
Media: Autodesk Maya, Adobe Illustrator, Adobe After Effects

This pharmaceutical animation describes VISKA.BIO’s approach to targeting cancer: by engineering a fusion protein with an antibody localizing it to the cancer and an enzyme that produces reactive oxygen species. This eventually results in immunogenic cell death of the cancer cells, producing markers that activate the body’s immune system so it targets cancer cells of the same type.

Storyboard, 2D assets and animation, 3D tumor and cells, and final compositing by Brittany Cheung
Protein and subcellular animations by Jonathan Khao
Narration by Jeannie Park